HIGHLIGHTS
- What: Although evidence justifying the use of etidronate in slowing vessel and joint calcification is scarce, the recent trial represents a step in the right direction.
- Who: Ali Akram Qureshi from the (UNIVERSITY) have published the Article: Etidronate for arterial calcification due to deficiency of CD73 (ACDC): a step in the right direction, in the Journal: (JOURNAL)
- Future: Although further research is needed to prove its efficacy this landmark study symbolizes a step in the right direction and underscores the need for continued investigation.
SUMMARY
The main outcomes of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.